Cipla Ltd.

BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%)
< Home < Back

Cipla wins Frost & Sullivan and TERI’s Sustainability 4.0 Award

Date: 13-01-2022

Cipla has been awarded winner as a “Challenger in Mega Large Business Pharma Sector” by Frost & Sullivan and TERI’s Sustainability 4.0 Awards. The award is a testimony to Cipla’s continuous efforts in the Environment, Social & Governance (ESG) space as a leader in the pharma industry. The company has been selected from a list of 50 reputed companies nominated for this award.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.